Literature DB >> 922726

Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii.

S W Barthold, A M Jonas.   

Abstract

The morphogenesis of 1, 2-dimethylhydrazine (DMH)-induced lesions in the colon of outbred NIH Swiss mice was determined for up to 5 months of treatment. The effect of hyperplasia on DMH carcinogenesis was also evaluated by introducing a transient hyperplastic stimulus to the colon during the chronic weekly treatment regimen of DMH. The hyperplastic stimulus was a naturally occurring disease of mice, transmissible murine colonic hyperplasia, which is caused by a variant of Citrobacter freundii. In control mice, those not receiving the bacterium, weekly injections of the carcinogen induced neoplastic changes first detectable at two months of treatment in all segments of the colon and in both sexes. The changes increased in frequency and severity with time. Diffuse mucosal hyperpladia and chronic inflammatory and degenerative changes were also associated with DMH after prolonged treatment. The hyperplastic stimulus of C. freundii reduced the latent period for appearance of early DMH tumors, but it had no influence on already established DMH tumors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 922726

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Suppression of aberrant transient receptor potential cation channel, subfamily V, member 6 expression in hyperproliferative colonic crypts by dietary calcium.

Authors:  Sara Peleg; Joseph H Sellin; Yu Wang; Michael R Freeman; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

Review 2.  Relationship between intestinal microbiota and colorectal cancer.

Authors:  Gokhan Cipe; Ufuk Oguz Idiz; Deniz Firat; Huseyin Bektasoglu
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.

Authors:  Hye Jin Choi; Juil Kim; Kee Hun Do; Seong-Hwan Park; Yuseok Moon
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

5.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

6.  beta-Catenin stabilization imparts crypt progenitor phenotype to hyperproliferating colonic epithelia.

Authors:  Joseph H Sellin; Yu Wang; Pomila Singh; Shahid Umar
Journal:  Exp Cell Res       Date:  2008-10-29       Impact factor: 3.905

7.  The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia.

Authors:  D B Schauer; S Falkow
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Hyperplasia and neoplasia of the intestinal tract.

Authors:  R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1979-09       Impact factor: 1.891

9.  Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.

Authors:  Emina Emilia Torlakovic; Vicki Keeler; Chang Wang; Hyun J Lim; Leslie Ann Lining; Suzanne Laferté
Journal:  BMC Cancer       Date:  2009-07-24       Impact factor: 4.430

10.  Attaching and effacing Escherichia coli downregulate DNA mismatch repair protein in vitro and are associated with colorectal adenocarcinomas in humans.

Authors:  Oliver D K Maddocks; Abigail J Short; Michael S Donnenberg; Scott Bader; David J Harrison
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.